Source link : https://www.newshealth.biz/health-news/can-dupilumab-halt-atopic-march-in-pediatric-ad/
TOPLINE: Pediatric patients with atopic dermatitis (AD) who are prescribed dupilumab may be at a reduced risk for atopic march progression, defined as the development of asthma or allergic rhinitis. METHODOLOGY: Researchers conducted a retrospective cohort study using data from the US Collaborative Network, focusing on pediatric patients aged 18 years and younger with two […]
Author : News Health
Publish date : 2024-06-19 03:44:12
Copyright for syndicated content belongs to the linked Source.
in Health